Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of Type-2 inflammation over inhibition of either pathway alone by Ramirez-Carrozzi, Vladimir, PhD, Sambandam, Arivazhagan, PhD, Zhou, Meijuan, BS, Yan, Donghong, MD, Kang, Jing, BS, Wu, Xiumin, PhD, Suto, Eric, Baca, Miriam, BA, Austin, Cary, MD, PhD, Xu, Min, MD, PhD, Lee, Wyne P., BVS, Pappu, Rajita, PhD

Get full text